Insights On Partnering
-
Clinical Trial Logistics: Meeting Unique Participant Needs
2/16/2024
Uncover why delivering a comprehensive service entails establishing a robust global network equipped with the expertise, resources, and adaptability to address diverse participant needs worldwide.
-
Why SSO Integrations Matter For Sites & Sponsors
10/8/2025
Multiple logins slow down site staff. Seamless SSO integrations reduce friction, eliminate extra steps, and help coordinators stay focused on trial execution—not portal management.
-
High Density, Low Availability: Rethinking Ophthalmic Trial Readiness
4/16/2025
The adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
-
Global Vaccine Trials Case Study
5/22/2024
Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.
-
Quotient Sciences Capacity Update July 2025
7/29/2025
Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.
-
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles
1/14/2026
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
-
How Real-World Data On Site Costs Accelerates Clinical Trial Success
10/23/2025
Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.
-
Improving Site Efficiency With Automated Drug Resupply And Forecasting
8/22/2025
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
Meeting 100% Recruitment 7 Months Ahead Of Schedule
7/23/2024
Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.
-
ePRO's Impact On Patient And Site Journeys
5/15/2024
Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.